Loading…
Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study
The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve. MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market...
Saved in:
Published in: | Journal of cardiothoracic surgery 2024-06, Vol.19 (1), p.340-10, Article 340 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033 |
container_end_page | 10 |
container_issue | 1 |
container_start_page | 340 |
container_title | Journal of cardiothoracic surgery |
container_volume | 19 |
creator | Micovic, Slobodan Nobre, Angelo Choi, Jae Woong Solinas, Marco Shehada, Sharaf-Eldin Torella, Michele Baeza, Cristian Parrino, Eugene Pollari, Francesco Troise, Giovanni Kappert, Utz Mellert, Friedrich Je, Hyung Gon Argano, Vincenzo Lam, Ka Yan Rinaldi, Mauro Gutermann, Herbert Meuris, Bart |
description | The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve.
MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days.
A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p |
doi_str_mv | 10.1186/s13019-024-02861-1 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c7ec43ffb2784ec389523ae90f903f7b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A798501173</galeid><doaj_id>oai_doaj_org_article_c7ec43ffb2784ec389523ae90f903f7b</doaj_id><sourcerecordid>A798501173</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033</originalsourceid><addsrcrecordid>eNptkkFv1DAUhCMEoqXwBzggS1y4pNixE8dc0KoqUGmBCtqz5TjPu14l8WI7i_bOD8fZlNJFKIoS-c180bxMlr0k-JyQunobCMVE5Lhg6a4rkpNH2SnhTOQ1Fvjxg_eT7FkIG4xZSXH5NDuhtcAFZ8Vp9utS-W6P3Bi16yEgZ5ByPlqNdqrbAfKw7ZSGHoaIftq4RtfgNaQZul7efkdhjKOHDkKY9e-SIYxdPIDiGtDWu7AFHW1i9WlgdSL5hP-8-HLzbYFCHNv98-yJUV2AF3fPs-z2w-XNxad8-fXj1cVimWvGypgzULQhmLe6YYbjFhctCIZbQuumEgoKUpqqopjTltVatJgbKDGh3GBqBKb0LLuaua1TG7n1tld-L52y8nDg_EqqKXsHUnPQjBrTFLxmoNPCyoIqEHgCGd4k1vuZtR2bHtpDLNUdQY8ng13LldtJQoggRcUT4c0dwbsfI4Qoexs0dJ0awI1BpiC4ppxTlqSv_5Fu3OiHtKtJJYqSCEH_qlYqJbCDcenDeoLKBRd1WgXhk-r8P6p0tdBb7QYwNp0fGYrZoNO_DB7MfUiC5VREORdRpiLKQxElSaZXD9dzb_nTPPobUcjZSg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3079251993</pqid></control><display><type>article</type><title>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</title><source>PubMed Central (Open Access)</source><source>ProQuest - Publicly Available Content Database</source><creator>Micovic, Slobodan ; Nobre, Angelo ; Choi, Jae Woong ; Solinas, Marco ; Shehada, Sharaf-Eldin ; Torella, Michele ; Baeza, Cristian ; Parrino, Eugene ; Pollari, Francesco ; Troise, Giovanni ; Kappert, Utz ; Mellert, Friedrich ; Je, Hyung Gon ; Argano, Vincenzo ; Lam, Ka Yan ; Rinaldi, Mauro ; Gutermann, Herbert ; Meuris, Bart</creator><creatorcontrib>Micovic, Slobodan ; Nobre, Angelo ; Choi, Jae Woong ; Solinas, Marco ; Shehada, Sharaf-Eldin ; Torella, Michele ; Baeza, Cristian ; Parrino, Eugene ; Pollari, Francesco ; Troise, Giovanni ; Kappert, Utz ; Mellert, Friedrich ; Je, Hyung Gon ; Argano, Vincenzo ; Lam, Ka Yan ; Rinaldi, Mauro ; Gutermann, Herbert ; Meuris, Bart ; MANTRA Investigators ; the MANTRA Investigators</creatorcontrib><description>The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve.
MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days.
A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p < 0.0001) and EQ-5D-5L VAS score (from 64.5 ± 20.4 to 72.6 ± 17.5, p < 0.0001). Mean pressure gradient decreased from 46.2 ± 17.3 mmHg to 10.1 ± 4.7 mmHg at 30-day follow-up. Low or no incidence of moderate-to-severe paravalvular or central leak was reported.
Preliminary results demonstrate good clinical outcomes and significant improvement of Quality of Life at 30-days, excellent early hemodynamic performance within patient implanted with Perceval PLUS.
The MANTRA study has been registered in ClinicalTrials.gov (NCT05002543, Initial release 26 July 2021).</description><identifier>ISSN: 1749-8090</identifier><identifier>EISSN: 1749-8090</identifier><identifier>DOI: 10.1186/s13019-024-02861-1</identifier><identifier>PMID: 38902742</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Aged ; Aged, 80 and over ; Aorta ; Aortic valve ; Aortic Valve - surgery ; Aortic valve replacement ; Aortic Valve Stenosis - surgery ; Catheters ; Disease ; Female ; Heart ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation - methods ; Heart valves ; Hemodynamics ; Hemodynamics - physiology ; Humans ; Male ; Middle Aged ; Mineralization ; Mortality ; Ostomy ; Patients ; Perceval plus ; Prospective Studies ; Prostheses ; Prosthesis Design ; Quality of Life ; Questionnaires ; Real-life data ; Recovery (Medical) ; Surgeons ; Surgery ; Sutureless Surgical Procedures - methods ; Sutureless valve ; Treatment Outcome</subject><ispartof>Journal of cardiothoracic surgery, 2024-06, Vol.19 (1), p.340-10, Article 340</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191267/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3079251993?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38902742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Micovic, Slobodan</creatorcontrib><creatorcontrib>Nobre, Angelo</creatorcontrib><creatorcontrib>Choi, Jae Woong</creatorcontrib><creatorcontrib>Solinas, Marco</creatorcontrib><creatorcontrib>Shehada, Sharaf-Eldin</creatorcontrib><creatorcontrib>Torella, Michele</creatorcontrib><creatorcontrib>Baeza, Cristian</creatorcontrib><creatorcontrib>Parrino, Eugene</creatorcontrib><creatorcontrib>Pollari, Francesco</creatorcontrib><creatorcontrib>Troise, Giovanni</creatorcontrib><creatorcontrib>Kappert, Utz</creatorcontrib><creatorcontrib>Mellert, Friedrich</creatorcontrib><creatorcontrib>Je, Hyung Gon</creatorcontrib><creatorcontrib>Argano, Vincenzo</creatorcontrib><creatorcontrib>Lam, Ka Yan</creatorcontrib><creatorcontrib>Rinaldi, Mauro</creatorcontrib><creatorcontrib>Gutermann, Herbert</creatorcontrib><creatorcontrib>Meuris, Bart</creatorcontrib><creatorcontrib>MANTRA Investigators</creatorcontrib><creatorcontrib>the MANTRA Investigators</creatorcontrib><title>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</title><title>Journal of cardiothoracic surgery</title><addtitle>J Cardiothorac Surg</addtitle><description>The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve.
MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days.
A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p < 0.0001) and EQ-5D-5L VAS score (from 64.5 ± 20.4 to 72.6 ± 17.5, p < 0.0001). Mean pressure gradient decreased from 46.2 ± 17.3 mmHg to 10.1 ± 4.7 mmHg at 30-day follow-up. Low or no incidence of moderate-to-severe paravalvular or central leak was reported.
Preliminary results demonstrate good clinical outcomes and significant improvement of Quality of Life at 30-days, excellent early hemodynamic performance within patient implanted with Perceval PLUS.
The MANTRA study has been registered in ClinicalTrials.gov (NCT05002543, Initial release 26 July 2021).</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aorta</subject><subject>Aortic valve</subject><subject>Aortic Valve - surgery</subject><subject>Aortic valve replacement</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Catheters</subject><subject>Disease</subject><subject>Female</subject><subject>Heart</subject><subject>Heart Valve Prosthesis</subject><subject>Heart Valve Prosthesis Implantation - methods</subject><subject>Heart valves</subject><subject>Hemodynamics</subject><subject>Hemodynamics - physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mineralization</subject><subject>Mortality</subject><subject>Ostomy</subject><subject>Patients</subject><subject>Perceval plus</subject><subject>Prospective Studies</subject><subject>Prostheses</subject><subject>Prosthesis Design</subject><subject>Quality of Life</subject><subject>Questionnaires</subject><subject>Real-life data</subject><subject>Recovery (Medical)</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Sutureless Surgical Procedures - methods</subject><subject>Sutureless valve</subject><subject>Treatment Outcome</subject><issn>1749-8090</issn><issn>1749-8090</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkkFv1DAUhCMEoqXwBzggS1y4pNixE8dc0KoqUGmBCtqz5TjPu14l8WI7i_bOD8fZlNJFKIoS-c180bxMlr0k-JyQunobCMVE5Lhg6a4rkpNH2SnhTOQ1Fvjxg_eT7FkIG4xZSXH5NDuhtcAFZ8Vp9utS-W6P3Bi16yEgZ5ByPlqNdqrbAfKw7ZSGHoaIftq4RtfgNaQZul7efkdhjKOHDkKY9e-SIYxdPIDiGtDWu7AFHW1i9WlgdSL5hP-8-HLzbYFCHNv98-yJUV2AF3fPs-z2w-XNxad8-fXj1cVimWvGypgzULQhmLe6YYbjFhctCIZbQuumEgoKUpqqopjTltVatJgbKDGh3GBqBKb0LLuaua1TG7n1tld-L52y8nDg_EqqKXsHUnPQjBrTFLxmoNPCyoIqEHgCGd4k1vuZtR2bHtpDLNUdQY8ng13LldtJQoggRcUT4c0dwbsfI4Qoexs0dJ0awI1BpiC4ppxTlqSv_5Fu3OiHtKtJJYqSCEH_qlYqJbCDcenDeoLKBRd1WgXhk-r8P6p0tdBb7QYwNp0fGYrZoNO_DB7MfUiC5VREORdRpiLKQxElSaZXD9dzb_nTPPobUcjZSg</recordid><startdate>20240621</startdate><enddate>20240621</enddate><creator>Micovic, Slobodan</creator><creator>Nobre, Angelo</creator><creator>Choi, Jae Woong</creator><creator>Solinas, Marco</creator><creator>Shehada, Sharaf-Eldin</creator><creator>Torella, Michele</creator><creator>Baeza, Cristian</creator><creator>Parrino, Eugene</creator><creator>Pollari, Francesco</creator><creator>Troise, Giovanni</creator><creator>Kappert, Utz</creator><creator>Mellert, Friedrich</creator><creator>Je, Hyung Gon</creator><creator>Argano, Vincenzo</creator><creator>Lam, Ka Yan</creator><creator>Rinaldi, Mauro</creator><creator>Gutermann, Herbert</creator><creator>Meuris, Bart</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240621</creationdate><title>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</title><author>Micovic, Slobodan ; Nobre, Angelo ; Choi, Jae Woong ; Solinas, Marco ; Shehada, Sharaf-Eldin ; Torella, Michele ; Baeza, Cristian ; Parrino, Eugene ; Pollari, Francesco ; Troise, Giovanni ; Kappert, Utz ; Mellert, Friedrich ; Je, Hyung Gon ; Argano, Vincenzo ; Lam, Ka Yan ; Rinaldi, Mauro ; Gutermann, Herbert ; Meuris, Bart</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aorta</topic><topic>Aortic valve</topic><topic>Aortic Valve - surgery</topic><topic>Aortic valve replacement</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Catheters</topic><topic>Disease</topic><topic>Female</topic><topic>Heart</topic><topic>Heart Valve Prosthesis</topic><topic>Heart Valve Prosthesis Implantation - methods</topic><topic>Heart valves</topic><topic>Hemodynamics</topic><topic>Hemodynamics - physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mineralization</topic><topic>Mortality</topic><topic>Ostomy</topic><topic>Patients</topic><topic>Perceval plus</topic><topic>Prospective Studies</topic><topic>Prostheses</topic><topic>Prosthesis Design</topic><topic>Quality of Life</topic><topic>Questionnaires</topic><topic>Real-life data</topic><topic>Recovery (Medical)</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Sutureless Surgical Procedures - methods</topic><topic>Sutureless valve</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Micovic, Slobodan</creatorcontrib><creatorcontrib>Nobre, Angelo</creatorcontrib><creatorcontrib>Choi, Jae Woong</creatorcontrib><creatorcontrib>Solinas, Marco</creatorcontrib><creatorcontrib>Shehada, Sharaf-Eldin</creatorcontrib><creatorcontrib>Torella, Michele</creatorcontrib><creatorcontrib>Baeza, Cristian</creatorcontrib><creatorcontrib>Parrino, Eugene</creatorcontrib><creatorcontrib>Pollari, Francesco</creatorcontrib><creatorcontrib>Troise, Giovanni</creatorcontrib><creatorcontrib>Kappert, Utz</creatorcontrib><creatorcontrib>Mellert, Friedrich</creatorcontrib><creatorcontrib>Je, Hyung Gon</creatorcontrib><creatorcontrib>Argano, Vincenzo</creatorcontrib><creatorcontrib>Lam, Ka Yan</creatorcontrib><creatorcontrib>Rinaldi, Mauro</creatorcontrib><creatorcontrib>Gutermann, Herbert</creatorcontrib><creatorcontrib>Meuris, Bart</creatorcontrib><creatorcontrib>MANTRA Investigators</creatorcontrib><creatorcontrib>the MANTRA Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of cardiothoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Micovic, Slobodan</au><au>Nobre, Angelo</au><au>Choi, Jae Woong</au><au>Solinas, Marco</au><au>Shehada, Sharaf-Eldin</au><au>Torella, Michele</au><au>Baeza, Cristian</au><au>Parrino, Eugene</au><au>Pollari, Francesco</au><au>Troise, Giovanni</au><au>Kappert, Utz</au><au>Mellert, Friedrich</au><au>Je, Hyung Gon</au><au>Argano, Vincenzo</au><au>Lam, Ka Yan</au><au>Rinaldi, Mauro</au><au>Gutermann, Herbert</au><au>Meuris, Bart</au><aucorp>MANTRA Investigators</aucorp><aucorp>the MANTRA Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study</atitle><jtitle>Journal of cardiothoracic surgery</jtitle><addtitle>J Cardiothorac Surg</addtitle><date>2024-06-21</date><risdate>2024</risdate><volume>19</volume><issue>1</issue><spage>340</spage><epage>10</epage><pages>340-10</pages><artnum>340</artnum><issn>1749-8090</issn><eissn>1749-8090</eissn><abstract>The aim of this study is to report the preliminary real-word clinical and hemodynamic performance from the MANTRA study in patients undergoing aortic valve replacement with Perceval PLUS sutureless valve.
MANTRA is an ongoing "umbrella" prospective, multi-center, international post-market study to collect real-life safety and performance data on Corcym devices (Corcym S.r.l, Saluggia, Italy). Clinical and echocardiographic outcomes were collected preoperatively, at discharge and at each follow up. KCCQ-12 and EQ-5D-5L quality of life questionnaires were collected preoperatively and at 30-days.
A total of 328 patients underwent aortic valve replacement with Perceval PLUS in 29 International institutions. Patients were enrolled from July 2021 to October 2023 and enrollment is still ongoing. Mean age was 71.9 ± 6.4 years, mean EuroSCORE II was 2.9 ± 3.9. Minimally invasive approach was performed in 44.2% (145/328) of patients; concomitant procedures were done in 40.8% (134/328) of cases. Thirty-day mortality was 1.8% (6/328) and no re-interventions were reported. Pacemaker implant was required in 4.0% (13/328) of the patients. The assessment of the functional status demonstrated marked and stable improvement in NYHA class in most patients at 30-day follow-up, with significant increase of KCCQ-12 summary score (from 58.8 ± 23.0 to 71.8 ± 22.1, p < 0.0001) and EQ-5D-5L VAS score (from 64.5 ± 20.4 to 72.6 ± 17.5, p < 0.0001). Mean pressure gradient decreased from 46.2 ± 17.3 mmHg to 10.1 ± 4.7 mmHg at 30-day follow-up. Low or no incidence of moderate-to-severe paravalvular or central leak was reported.
Preliminary results demonstrate good clinical outcomes and significant improvement of Quality of Life at 30-days, excellent early hemodynamic performance within patient implanted with Perceval PLUS.
The MANTRA study has been registered in ClinicalTrials.gov (NCT05002543, Initial release 26 July 2021).</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38902742</pmid><doi>10.1186/s13019-024-02861-1</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1749-8090 |
ispartof | Journal of cardiothoracic surgery, 2024-06, Vol.19 (1), p.340-10, Article 340 |
issn | 1749-8090 1749-8090 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c7ec43ffb2784ec389523ae90f903f7b |
source | PubMed Central (Open Access); ProQuest - Publicly Available Content Database |
subjects | Aged Aged, 80 and over Aorta Aortic valve Aortic Valve - surgery Aortic valve replacement Aortic Valve Stenosis - surgery Catheters Disease Female Heart Heart Valve Prosthesis Heart Valve Prosthesis Implantation - methods Heart valves Hemodynamics Hemodynamics - physiology Humans Male Middle Aged Mineralization Mortality Ostomy Patients Perceval plus Prospective Studies Prostheses Prosthesis Design Quality of Life Questionnaires Real-life data Recovery (Medical) Surgeons Surgery Sutureless Surgical Procedures - methods Sutureless valve Treatment Outcome |
title | Early outcomes of aortic valve replacement with Perceval PLUS sutureless valve: results of the prospective multicentric MANTRA study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20outcomes%20of%20aortic%20valve%20replacement%20with%20Perceval%20PLUS%20sutureless%20valve:%20results%20of%20the%20prospective%20multicentric%20MANTRA%20study&rft.jtitle=Journal%20of%20cardiothoracic%20surgery&rft.au=Micovic,%20Slobodan&rft.aucorp=MANTRA%20Investigators&rft.date=2024-06-21&rft.volume=19&rft.issue=1&rft.spage=340&rft.epage=10&rft.pages=340-10&rft.artnum=340&rft.issn=1749-8090&rft.eissn=1749-8090&rft_id=info:doi/10.1186/s13019-024-02861-1&rft_dat=%3Cgale_doaj_%3EA798501173%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-4ea3b107dcb4f70d02de940d138b69ae215f663073d48c9d07fe50137f03f9033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3079251993&rft_id=info:pmid/38902742&rft_galeid=A798501173&rfr_iscdi=true |